Table of Content

Table of Contents

Global Biosimilar Market Segment Research Report 2021
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Biosimilar Market by Value
2.2.1 Global Biosimilar Revenue by Type
2.2.2 Global Biosimilar Market by Value (%)
2.3 Global Biosimilar Market by Production
2.3.1 Global Biosimilar Production by Type
2.3.2 Global Biosimilar Market by Production (%)

3. The Major Driver of Biosimilar Industry
3.1 Historical & Forecast Global Biosimilar Demand
3.2 Largest Application for Biosimilar (2017-2027)
3.3 The Major Downstream Company in China Market 2021

4. Global and Regional Biosimilar Market
4.1 Regional Market Size in Terms of Production & Demand (2021)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of Biosimilar Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Biosimilar Production, Demand (2017-2027)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe Biosimilar Production, Demand (2017-2027)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China Biosimilar Production, Demand (2017-2027)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan Biosimilar Production, Demand (2017-2027)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India Biosimilar Production, Demand (2017-2027)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea Biosimilar Production, Demand (2017-2027)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia Biosimilar Production, Demand (2017-2027)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global Biosimilar Average Price Trend
12.1 Market Price for Each Type of Biosimilar in US (2017-2021)
12.2 Market Price for Each Type of Biosimilar in Europe (2017-2021)
12.3 Market Price for Each Type of Biosimilar in China (2017-2021)
12.4 Market Price for Each Type of Biosimilar in Japan (2017-2021)
12.5 Market Price for Each Type of Biosimilar in India (2017-2021)
12.6 Market Price for Each Type of Biosimilar in Korea (2017-2021)
12.7 Market Price for Each Type of Biosimilar in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
13.1 Biosimilar Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of Biosimilar

14. Biosimilar Competitive Landscape
14.1 Pfizer
14.1.1 Pfizer Company Profiles
14.1.2 Pfizer Product Introduction
14.1.3 Pfizer Biosimilar Sales, Revenue (2017-2021)
14.1.4 Strategic initiatives
14.2 Roche
14.2.1 Roche Company Profiles
14.2.2 Roche Product Introduction
14.2.3 Roche Biosimilar Sales, Revenue (2017-2021)
14.2.4 Strategic initiatives
14.3 Eli Lilly
14.3.1 Eli Lilly Company Profiles
14.3.2 Eli Lilly Product Introduction
14.3.3 Eli Lilly Biosimilar Sales, Revenue (2017-2021)
14.3.4 Strategic initiatives
14.4 Bayer
14.4.1 Bayer Company Profiles
14.4.2 Bayer Product Introduction
14.4.3 Bayer Biosimilar Sales, Revenue (2017-2021)
14.4.4 Strategic initiatives
14.5 Amgen
14.5.1 Amgen Company Profiles
14.5.2 Amgen Product Introduction
14.5.3 Amgen Biosimilar Sales, Revenue (2017-2021)
14.5.4 Strategic initiatives
14.6 Sanofi-Aventis
14.6.1 Sanofi-Aventis Company Profiles
14.6.2 Sanofi-Aventis Product Introduction
14.6.3 Sanofi-Aventis Biosimilar Sales, Revenue (2017-2021)
14.6.4 Strategic initiatives
14.7 Johnson & Johnson
14.7.1 Johnson & Johnson Company Profiles
14.7.2 Johnson & Johnson Product Introduction
14.7.3 Johnson & Johnson Biosimilar Sales, Revenue (2017-2021)
14.7.4 Strategic initiatives
14.8 Novo Nordisk
14.8.1 Novo Nordisk Company Profiles
14.8.2 Novo Nordisk Product Introduction
14.8.3 Novo Nordisk Biosimilar Sales, Revenue (2017-2021)
14.8.4 Strategic initiatives
14.9 Merck
14.9.1 Merck Company Profiles
14.9.2 Merck Product Introduction
14.9.3 Merck Biosimilar Sales, Revenue (2017-2021)
14.9.4 Strategic initiatives
15. Conclusion

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Biosimilar Industry (Volume)
Figure 2. Biosimilar Production & Demand by Regions in 2021
Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
Figure 4. The Top 10 and 5 Players Market Share by Biosimilar Revenue in 2021
Figure 5. US Biosimilar Production, Demand (2017-2027)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Biosimilar Production, Demand (2017-2027)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Biosimilar Production, Demand (2017-2027)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Biosimilar Production, Demand (2017-2027)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Biosimilar Production, Demand (2017-2027)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Biosimilar Production, Demand (2017-2027)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Biosimilar Production, Demand (2017-2027)
Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Biosimilar Revenue, by Type (Million USD) (2017-2027)
Table 4. Biosimilar Production, by Type (K Unit) (2017-2027)
Table 5. Biosimilar Demand (K Unit) by Application (2017-2027)
Table 6. Biosimilar Demand (Million USD) by Application (2017-2027)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2021)
Table 9. Regional Market Share in Terms of Revenue (2021&2027)
Table 10. Ranking of Global Top Biosimilar Companies by Revenue, Concentration Ratio in 2021
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Biosimilar Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Biosimilar Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Biosimilar Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Biosimilar Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Biosimilar Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Biosimilar Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Biosimilar Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Biosimilar in US (2017-2021)
Table 53. Market Price (USD/Unit) for Each Type of Biosimilar in Europe (2017-2021)
Table 54. Market Price (USD/Unit) for Each Type of Biosimilar in China (2017-2021)
Table 55. Market Price (USD/Unit) for Each Type of Biosimilar in Japan (2017-2021)
Table 56. Market Price (USD/Unit) for Each Type of Biosimilar in India (2017-2021)
Table 57. Market Price (USD/Unit) for Each Type of Biosimilar in Korea (2017-2021)
Table 58. Market Price (USD/Unit) for Each Type of Biosimilar in Southeast Asia (2017-2021)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Pfizer Profiles
Table 61. Pfizer Biosimilar Product Introduction
Table 62. Pfizer Biosimilar Sales (Unit), Revenue (Million USD) (2017-2021)
Table 63. Pfizer Strategic initiatives
Table 64. Roche Profiles
Table 65. Roche Biosimilar Product Introduction
Table 66. Roche Biosimilar Sales (Unit), Revenue (Million USD) (2017-2021)
Table 67. Roche Strategic initiatives
Table 68. Eli Lilly Profiles
Table 69. Eli Lilly Biosimilar Product Introduction
Table 70. Eli Lilly Biosimilar Sales (Unit), Revenue (Million USD) (2017-2021)
Table 71. Eli Lilly Strategic initiatives
Table 72. Bayer Profiles
Table 73. Bayer Biosimilar Product Introduction
Table 74. Bayer Biosimilar Sales (Unit), Revenue (Million USD) (2017-2021)
Table 75. Bayer Strategic initiatives
Table 76. Amgen Profiles
Table 77. Amgen Biosimilar Product Introduction
Table 78. Amgen Biosimilar Sales (Unit), Revenue (Million USD) (2017-2021)
Table 79. Amgen Strategic initiatives
Table 80. Sanofi-Aventis Profiles
Table 81. Sanofi-Aventis Biosimilar Product Introduction
Table 82. Sanofi-Aventis Biosimilar Sales (Unit), Revenue (Million USD) (2017-2021)
Table 83. Sanofi-Aventis Strategic initiatives
Table 84. Johnson & Johnson Profiles
Table 85. Johnson & Johnson Biosimilar Product Introduction
Table 86. Johnson & Johnson Biosimilar Sales (Unit), Revenue (Million USD) (2017-2021)
Table 87. Johnson & Johnson Strategic initiatives
Table 88. Novo Nordisk Profiles
Table 89. Novo Nordisk Biosimilar Product Introduction
Table 90. Novo Nordisk Biosimilar Sales (Unit), Revenue (Million USD) (2017-2021)
Table 91. Novo Nordisk Strategic initiatives
Table 92. Merck Profiles
Table 93. Merck Biosimilar Product Introduction
Table 94. Merck Biosimilar Sales (Unit), Revenue (Million USD) (2017-2021)